08
Jul

AstraZeneca is expanding iMed, its virtual R&D project, through a cardiovascular-focused agreement with Germany’s Max Planck Institute of Molecular Physiology that will focus on early-stage research.

…read more

Source: AstraZeneca spreads its virtual reach to cardio R&D with new partnership

    

0 No comments